Publikationen in Zusammenarbeit mit Forschern von Universidad Politécnica de Valencia (21)

2022

  1. Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1

    International journal of molecular sciences, Vol. 23, Núm. 15

2021

  1. Evaluation of Extracellular Vesicles from Adipose Tissue-Derived Mesenchymal Stem Cells in Primary Human Chondrocytes from Patients with Osteoarthritis

    Methods in Molecular Biology (Humana Press Inc.), pp. 221-231

  2. Extracellular vesicles do not mediate the anti-inflammatory actions of mouse-derived adipose tissue mesenchymal stem cells secretome

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-14

2020

  1. Extracellular vesicles from mesenchymal stem cells as novel treatments for musculoskeletal diseases

    Cells, Vol. 9, Núm. 1

  2. Pharmacological modulation of redox signaling pathways in disease

    Free Radical Biology and Medicine

  3. Relevance of Nrf2 and heme oxygenase-1 in articular diseases

    Free Radical Biology and Medicine, Vol. 157, pp. 83-93

2019

  1. Emerging therapeutic agents in osteoarthritis

    Biochemical Pharmacology, Vol. 165, pp. 4-16

  2. Extracellular Vesicles from Mesenchymal Stem Cells as Novel Treatments for Musculoskeletal Diseases

    Cells, Vol. 9, Núm. 1

  3. Osteostatin inhibits collagen-induced arthritis by regulation of immune activation, pro-inflammatory cytokines, and osteoclastogenesis

    International Journal of Molecular Sciences, Vol. 20, Núm. 16

2018

  1. Extracellular vesicles: A new therapeutic strategy for joint conditions

    Biochemical Pharmacology, Vol. 153, pp. 134-146

  2. Microvesicles from Human Adipose Tissue-Derived Mesenchymal Stem Cells as a New Protective Strategy in Osteoarthritic Chondrocytes

    Cellular Physiology and Biochemistry, Vol. 47, Núm. 1, pp. 11-25

  3. Myeloid heme oxygenase-1 regulates the acute inflammatory response to zymosan in the mouse air pouch

    Oxidative Medicine and Cellular Longevity, Vol. 2018

  4. Nrf2 as a therapeutic target for rheumatic diseases

    Biochemical Pharmacology, Vol. 152, pp. 338-346

  5. Paracrine anti-inflammatory effects of adipose tissue-derived mesenchymal stem cells in human monocytes

    Frontiers in Physiology, Vol. 9, Núm. MAY

  6. Transcription factor NRF2 as a therapeutic target for chronic diseases: A systems medicine approach

    Pharmacological Reviews, Vol. 70, Núm. 2, pp. 348-383

2017

  1. Ex Vivo Tracking of Endogenous CO with a Ruthenium(II) Complex

    Journal of the American Chemical Society, Vol. 139, Núm. 51, pp. 18484-18487

  2. Extracellular vesicles from adipose-derived mesenchymal stem cells downregulate senescence features in osteoarthritic osteoblasts

    Oxidative Medicine and Cellular Longevity, Vol. 2017

  3. Targeting inflammasome by the inhibition of caspase-1 activity using capped mesoporous silica nanoparticles

    Journal of Controlled Release, Vol. 248, pp. 60-70

2015

  1. A Boron Dipyrromethene (BODIPY)-Based CuII-Bipyridine Complex for Highly Selective NO Detection

    Chemistry - A European Journal, Vol. 21, Núm. 44, pp. 15486-15490

2013

  1. CO-releasing binuclear rhodium complexes as inhibitors of nitric oxide generation in stimulated macrophages

    Inorganic Chemistry, Vol. 52, Núm. 24, pp. 13806-13808